التفاصيل البيبلوغرافية
| العنوان: |
Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment. |
| المؤلفون: |
Riedl, Julia1,2 (AUTHOR), Popp, Courtney1,3 (AUTHOR), Eide, Cindy3 (AUTHOR), Ebens, Christen3 (AUTHOR), Tolar, Jakub1,2,3 (AUTHOR) tolar003@umn.edu |
| المصدر: |
Cytotherapy (Elsevier Inc.). Nov2021, Vol. 23 Issue 11, p961-973. 13p. |
| مصطلحات موضوعية: |
*EPIDERMOLYSIS bullosa, *STROMAL cells, *WOUND healing, *MICROBIAL invasiveness, *REGENERATIVE medicine, *SKIN regeneration |
| مستخلص: |
Mesenchymal stromal cells (MSCs) are multi-potent stromal-derived cells capable of self-renewal that possess several advantageous properties for wound healing, making them of interest to the field of dermatology. Research has focused on characterizing the unique properties of MSCs, which broadly revolve around their regenerative and more recently discovered immunomodulatory capacities. Because of ease of harvesting and expansion, differentiation potential and low immunogenicity, MSCs have been leading candidates for tissue engineering and regenerative medicine applications for wound healing, yet results from clinical studies have been variable, and promising pre-clinical work has been difficult to reproduce. Therefore, the specific mechanisms of how MSCs influence the local microenvironment in distinct wound etiologies warrant further research. Of specific interest in MSC-mediated healing is harnessing the secretome, which is composed of components known to positively influence wound healing. Molecules released by the MSC secretome can promote re-epithelialization and angiogenesis while inhibiting fibrosis and microbial invasion. This review focuses on the therapeutic interest in MSCs with regard to wound healing applications, including burns and diabetic ulcers, with specific attention to the genetic skin disease recessive dystrophic epidermolysis bullosa. This review also compares various delivery methods to support skin regeneration in the hopes of combating the poor engraftment of MSCs after delivery, which is one of the major pitfalls in clinical studies utilizing MSCs. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
